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The binding of [3H]ryanodine to liver microsomal subfractions was investigated. The smooth microsomal membranes were enriched with ryanodine 
binding sites and also with a polypeptide of360 kDa. Caffeine completely inhibited [3H]ryanodine binding. Ryanodine also affected the membrane 
Ca 2+ permeability. At low concentrations (< I0 #M) ryanodine stimulated Ca 2+ efltux and at higher concentrations (>50 #M) it blocked Ca 2+ 
efflux. These results uggest that hepatic microsomes contain ryanodine binding sites which can modify the membrane permeability for Ca 2÷. 
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1. INTRODUCTION 
Ryanodine is a highly toxic neutral alkaloid that 
causes an irreversible contracture of skeletal muscle 
and a decrease in the developed tension of cardiac mus- 
cle [1]. These effects are due to the interaction of 
ryanodine with the SR, thereby modulating the Ca 2÷ 
release activity of this membrane [2,3]. Recent studies 
identified morphologically the purified ryanodine 
receptor with the 'foot' structure [4] and with the junc- 
tional Ca 2÷ release channel [5-7]. The purified 
ryanodine receptor is a large, 30S complex comprised 
of a single polypeptide with apparent relative molecular 
mass (Mr) of 400000 (400 kDa). Recently, however, the 
ryanodine receptor from skeletal muscle has been clon- 
ed and a molecular weight of 565 000 Da was determin- 
ed [8,9]. 
Although it is now accepted that the principal site of 
ryanodine action is the SR, these previous studies did 
not rule out the possibility that specific ryanodine bin- 
ding sites might be also present in non-excitable tissues. 
This possibility was, therefore, explored in the present 
study by using hepatic microsomal fractions. 
Mops, pH 7.1, and 1 mM DTT containing the following protease in- 
hibitors: 0.8 mM benzamidine; 0.5 #g/ml aprotinin; 0.2 mM 
phenylmethylsulfonylfluoride. Microsomes were fractionated by Cs- 
containing sucrose-density-gradient c rifugation [11] into: rough 
ER (pellet); the membranes at 1.3 M sucrose phase; intermediate ER 
and the 1.3/0.75 M sucrose interface, smooth ER. The microsomes 
were quickly frozen in liquid nitrogen and stored at -70°C. The pro- 
tein concentration was determined as described previously [12]. 
2.2. Ca 2+ efflux 
This was assayed as described in the legend to Fig. 3. 
2.3. l~HlRyanodine binding 
Equilibrium binding to the different microsomal fractions was 
determined by incubation of the membranes (1 mg/ml), for 10 min 
at 37°C in 0.5 M NaC1; 20 mM Tris-HC1, pH 7.4; 0.5 mM EGTA, 
and 20 nM [3H]ryanodine (60 Ci/mmol). The unbound ryanodine 
was separated from protein-bound ryanodine by the filtration 
method. Protein aliquots (80#g) were filtered through 0.22#m 
Millipore filters and washed two times with 5 ml of cold washing buf- 
fer containing 0.2 M NaCI, and 10 mM Hepes, pH 7.4. The counts 
retained on the filters were determined using liquid scintillation coun- 
ting techniques. 
2.4. SDS-polyacrylamide g l electrophoresis 
This was performed as described by Laemmli [131. 
2. MATERIALS AND METHODS 
2.1. Membrane preparations 
Liver microsomes were prepared from male Sprague-Dawley rats as 
described previously [10], except that the liver was homogenized and 
the 105000 x g pellet was resuspended in 0.25 M sucrose; 10 mM 
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3. RESULTS AND DISCUSSION 
Microsomal membranes, prepared from rat liver, 
were subfractionated by sucrose-density gradient cen- 
trifugation to three subfractions: mooth membranes at 
the 0.75/1.3 M sucrose interface; intermediate mem- 
branes at the 1.3 M sucrose phase; and the rough mem- 
branes sedimenting as the pellet. The electrophoretic 
protein pattern of these fractions demonstrated the 
presence of a high molecular weight protein doublet of 
about 360 kDa, which is considerably enriched in the 
smooth membrane fraction (Fig. 1). The smooth ER 
fraction is also enriched with two other protein bands 
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Fig. 1. Gel-electrophoresis pattern of liver microsome subfractions; 
an enrichment in 360 kDa protein band in the smooth ER fraction. 
Liver microsomes (lane 1) were fractionated by Cs-containing 
sucrose-density-gradient c rifugation into: rough ER (lane 2); 
intermediate ER (lane 3); and smooth ER (lane 4) as described in 
section 2. Samples (100 ug) were solubilized in SDS and proteins were 
separated on 4-13% gradient SDS-polyacrylamide gels using a 3% 
stacking el. In the heavy fraction of skeletal muscle SR (lane 5), the 
ryanodine receptor, the (Ca 2+ + Mg2+)ATPase and calsequestrin (CS) 
are indicated. Molecular weight standards were myosin, B- 
galactosidase, phosphorylase b, bovine serum albumin, and 
ovalbumin, with their respective molecular weights at 200000, 
116000, 92500, 66200 and 45000. (Bio-Rad). 
of  260 and 170 kDa. We have found (results not 
shown) that four proteins cross-reacted with the affini- 
ty purified polyclonal antibodies against the 360 kDa 
protein (ryanodine receptor) of  the rabbit sarcoplasmic 
reticulum [14]. These proteins were 360 and 260 kDa, 
and a protein doublet of  200-170 kDa. Although 
several protease inhibitors were used during the 
microsomal preparation, we cannot rule out the 
possibility that the 260 and 170 kDa polypeptides are 
degradation products of  the 360 kDa protein. 
To test whether the protein(s) which cross-reacted 
with the antibodies against the SR ryanodine receptor 
represent ryanodine binding protein, we measured the 
binding of  [3H]ryanodine to the different membranes 
fractions. [3H]Ryanodine binds to high affinity sites 
enriched in the smooth membrane fraction (Table I). 
The binding of  [3H]ryanodine to the smooth mem- 
branes is about 1.6- and 2-fold higher than the binding 
to the unfractionated microsomes or rough ER, respec- 
tively. A single class of  binding sites with Kd of  8 nM 
and total binding sites (Bmax) of 600 fmo1/mg protein 
were obtained by Scatchard analysis of  saturation 
isotherms of  ryanodine binding results (data not 
shown). Quantitative correlation between the 360 kDa 
polypeptide, present in the different fractions (Fig. 1), 
and the specific binding of  ryanodine (Table I) could 
not be carried out. This is because the binding values of  
the different fractions do not represent he maximal 
binding due to their different filtering efficiency with 
regard to loss of  membranes through the 0.22/gzm 
Millipore filters (data not shown). 
The liver is supplied with blood through vessels 
which contain some smooth muscle. Though their 
amount in comparison to the liver mass is negligible, it 
seemed important to verify that ryanodine binds to 
microsomes derived from parenchymal cells. The 
possibility that ryanodine binding sites originate from 
smooth muscle was ruled out by fractionation of  
microsomes prepared from isolated hepatocytes. Both 
ryanodine binding to these subfractions and the enrich- 
ment in the 360 kDa protein in the smooth fraction 
were similar to those obtained with microsomes 
prepared from whole liver. Moreover, further purifica- 
tion of  the smooth ER fraction on Mg 2+ sucrose gra- 
dient [15] resulted in an increase in [3H]ryanodine 
binding capacity of  the membranes. 
Caffeine, at concentrations which promote Ca z+ 
release from SR [16], inhibited the binding of  
[3H]ryanodine to the liver smooth ER membranes 
(Fig. 2). It should be mentioned that caffeine-sensitive 
Ca 2+ stores have been demonstrated in non-muscle 
tissue, the rat sympathetic neuron [17]. Also, it has 
been proposed that a 170 kDa protein of  the SR is the 
caffeine receptor of  the Ca z+ release channel [18]. 
If as suggested, ryanodine is a Ca 2+ release channel- 
specific marker [3,6,19,20] then it should affect the 
Ca 2+ permeability of  the liver microsomes. This was 
tested by determining the Ca z+ permeability of  vesicles 
passively loaded with 45CaZ+ in the presence and 
absence of ryanodine. We have found that at concen- 
trations below 10/~M ryanodine stimulated Ca 2÷ ef- 
flux, while at higher concentrations it blocked 
Ca2+-permeable pathway(s) activated by low concen- 
Table 1 
Ryanodine binding by different subfractions of liver microsomes 
Fraction [3H]Ryanodine binding 
(fmol/mg protein) 
Total Specific 
Microsomes 520 344 
Rough ER 383 244 
Intermediate ER 629 404 
Smooth ER 770 544 
The different membrane fractions were isolated and [3H]ryanodine 
binding was measured as described in section 2. This is a 
representative experiment of 12 different membrane preparations. 
The results are the averages of duplicate samples which differed by 
1-5%. The nonspecific binding was determined in the presence of 
100/zM of unlabeled ryanodine. It should be mentioned that we used 
a high concentration of the unlabeled ryanodine, because of the 
presence of low affinity binding sites for ryanodine (Shoshan- 
Barmatz, V. and Kraus-Friedmann, N., unpublished results). 
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Fig. 2. Caffeine inhibition of [3H]ryanodine binding to liver smooth 
ER. [3H]Ryanodine binding was assayed in the absence and the 
presence of the indicated concentrations of caffeine, as described in 
section 2. Specific binding in the absence of caffeine (100%) = 
363 fmol/mg protein. Specific binding represents the difference 
between total binding (with [3H]ryanodine alone) and nonspecific 
binding (with [3H]ryanodine and 100,uM unlabeled ryanodine). 
tration of ryanodine or by the presence of EGTA 
(Fig. 3). 
Thus, our results are similar to those reported for the 
skeletal and cardiac muscle sarcoplasmic reticulum 
[19-21], and suggest hat smooth ER membranes con- 
tain a Ca z* release channel which can be activated or 
inhibited by ryanodine, depending on the experimental 
conditions. On the other hand, the liver ryanodine 
receptor differs from the cardiac and skeletal muscle 
receptors by its fast association and dissociation (both 
reached steady state at less than 5 min at 24°C), by its 
CaZ+-independent binding, and by its insensitivity to 
Ruthenium red and Mg 2+ (Shoshan-Barmatz and 
Kraus-Friedmann, unpublished results). These observa- 
tions suggest that the ryanodine binding sites in the 
liver microsomes are exposed, in contrast o the cardiac 
and skeletal SR membranes where ryanodine binds to 
a site which is accessible only in the open state of the 
Ca 2+ release channel/ryanodine receptor [19]. The 
observed ifferences between the liver and the muscle 
ryanodine binding sites are not surprising in light of the 
noticeable differences between the cardiac and the 
skeletal muscle ryanodine receptors, such as their 
molecular weight and their sensitivity to Mg 2+, Ca 2+ 
and Ruthenium red [22-24]. 
The presented ata demonstrates the existence of a 
ryanodine binding protein/Ca 2+ release system in the 
liver. This is the first demonstration of such activities 
in non-excitable tissue. However, ryanodine binding to 
brain microsomal preparation with similar Kd and Bmax 
as we have obtained for the liver was reported recently 
[25]. These findings raise the possibility that the 
ryanodine-receptor/Ca 2+ release system has a wider 
distribution and role in CaZ+-regulated processes than 
previously considered. 
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Fig. 3. Effect of ryanodine on the Ca 2÷ permeability of isolated liver 
microsomes. Microsomes (5 mg/ml) were loaded with 5 mM CaC12 
(containing 45Ca, 3.4 x 103 cpm/nmol) by incubation for 1 h at 37°C 
in a medium containing 100 mM KC1 and 20 mM Mops, pH 6.8 in 
the absence or the presence of the indicated concentrations of
ryanodine. For Ca 2÷ efflux assay, the loaded vesicles (20 tzl) were 
placed on 0.22/zm Millipore filters and rinsed with different volumes 
of 0.1 M KCI and 10 mM Mops, pH 6.8 (B) or with the same solution 
containing 1mM EGTA (C), for the indicated time. The flow rate 
was 1 ml/s. The dependence of 45Ca2+ efflux on ryanodine 
concentration is shown in the upper part of the figure. Closed 
symbols indicate 45CaZ+ efflux assayed in the absence, and open 
symbols in the presence of 1 mM EGTA. 
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